Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer

Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer in a Tertiary Care Hospital: A Prospective Observational Study

The goal of this prospective observational study is to observe the effectiveness of pain management interventions in patients with abdominal and pelvic cancer pain.

The main question[s] it aims to answer are:

• The effectiveness of pain management interventions.
• The frequency of pain intervention procedures and side effects and complications of pain management interventions

Study Overview

• Status: Not yet recruiting
• Conditions: Abdominal Cancer

• Study Type: Observational
• Enrollment (Estimated): 100

Contacts and Locations

• Study Contact: Name: Ali Sarfraz Siddiqui, MBBS, FCPS; Phone Number: 4397 00922134864397; Email: sarfraz.siddiqui@aku.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patients with chronic pain due to abdominal and pelvic cancer.

Description

Inclusion Criteria:

• Patients with chronic pain due to abdominal and pelvic cancer
• Both Male and Female
• Ages18-65 years
• Patients who with recurrence or metastasis

Exclusion Criteria:

• Patients who refuse to give consent
• Patients who were lost to follow up after initial visit or assessment
• History of severe depression or psychiatric illness
• History of surgical procedure due to cancer
• Patients with DNR code

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Patient reported NRS score	Numeric Rating Score from 0 (no pain)- 10 (severe pain)	First visit and then at 3 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of patients	Number of patients on whom the intervention is performed.	From 2 weeks to 3 months.

Collaborators and Investigators

• Sponsor: Aga Khan University

Study record dates

Study Major Dates

• Study Start (Estimated): January 16, 2026
• Primary Completion (Estimated): October 15, 2026
• Study Completion (Estimated): December 31, 2026

Study Registration Dates

• First Submitted: January 15, 2026
• First Submitted That Met QC Criteria: January 15, 2026
• First Posted (Actual): January 22, 2026

Study Record Updates

• Last Update Posted (Actual): January 22, 2026
• Last Update Submitted That Met QC Criteria: January 15, 2026
• Last Verified: January 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: 2025-12177-38695

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No